Literature DB >> 15913493

Prolonged activation of the baroreflex: a viable approach for the treatment of hypertension?

Thomas E Lohmeier1, Austin M Barrett, Eric D Irwin.   

Abstract

In most patients with hypertension, arterial pressure is above the target level for control, even in those individuals taking multiple antihypertensive drugs. In this article, we review the history and current status of a nonpharmacologic approach for the treatment of hypertension--chronic electrical activation of the afferent limb of the carotid baroreflex. Recent studies in normotensive and hypertensive dogs have clearly demonstrated impressive and sustained reductions in arterial pressure and sympathetic activity during prolonged baroreflex activation. Clinical trials are now underway in Europe, and clinical investigation in the United States will begin this year to evaluate the efficacy of this therapy in patients with resistant hypertension.

Entities:  

Mesh:

Year:  2005        PMID: 15913493     DOI: 10.1007/s11906-005-0009-0

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  18 in total

1.  Sustained increases in plasma epinephrine concentration do not modulate renin release.

Authors:  H M Yang; T E Lohmeier; S D Kivlighn; R G Carroll; M J Smith
Journal:  Am J Physiol       Date:  1989-07

Review 2.  Recent insights into the interactions between the baroreflex and the kidneys in hypertension.

Authors:  Thomas E Lohmeier; Drew A Hildebrandt; Susan Warren; Paul J May; J Thomas Cunningham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-04       Impact factor: 3.619

Review 3.  Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions.

Authors:  M Esler; G Jennings; G Lambert; I Meredith; M Horne; G Eisenhofer
Journal:  Physiol Rev       Date:  1990-10       Impact factor: 37.312

4.  Effects of electrical stimulation of the carotid sinus nerve in reversal of experimentally induced hypertension.

Authors:  A Neistadt; S I Schwartz
Journal:  Surgery       Date:  1967-06       Impact factor: 3.982

5.  Adrenergic and reflex abnormalities in obesity-related hypertension.

Authors:  G Grassi; G Seravalle; R Dell'Oro; C Turri; G B Bolla; G Mancia
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

Review 6.  The sympathetic system and hypertension.

Authors:  M Esler
Journal:  Am J Hypertens       Date:  2000-06       Impact factor: 2.689

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Plasma renin activity during hypotensive responses to electrical stimulation carotid sinus nerves in conscious dogs.

Authors:  T K Peters; G Kaczmarczyk
Journal:  Clin Exp Pharmacol Physiol       Date:  1994-01       Impact factor: 2.557

9.  Prolonged activation of the baroreflex produces sustained hypotension.

Authors:  Thomas E Lohmeier; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2004-01-05       Impact factor: 10.190

Review 10.  Causes and consequences of increased sympathetic activity in renal disease.

Authors:  Jaap A Joles; Hein A Koomans
Journal:  Hypertension       Date:  2004-02-23       Impact factor: 10.190

View more
  13 in total

Review 1.  Implantable device therapy for the treatment of resistant hypertension.

Authors:  Nikhil Joshi; Jeremy Taylor; John D Bisognano
Journal:  J Cardiovasc Transl Res       Date:  2009-03-04       Impact factor: 4.132

Review 2.  The future of endothelin-receptor antagonism as treatment for systemic hypertension.

Authors:  Gabriel Vorobiof; Burns C Blaxall; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

3.  Baroreflex device therapy in the treatment of hypertension.

Authors:  Sarada C Uppuluri; Eugene Storozynsky; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

Review 4.  Apneic Sleep, Insufficient Sleep, and Hypertension.

Authors:  Meghna P Mansukhani; Naima Covassin; Virend K Somers
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

5.  Renal Denervation to Treat Heart Failure.

Authors:  Thomas E Sharp; David J Lefer
Journal:  Annu Rev Physiol       Date:  2020-10-19       Impact factor: 19.318

Review 6.  Baroreflex stimulation in antihypertensive treatment.

Authors:  Jeremy G Taylor; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

Review 7.  Chronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapy.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

8.  Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension.

Authors:  James P Fisher; Paul J Fadel
Journal:  Exp Physiol       Date:  2010-03-19       Impact factor: 2.969

9.  Mechanisms of blood pressure reduction by prolonged activation of the baroreflex.

Authors:  Radu Iliescu; Thomas E Lohmeier
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

Review 10.  Chemoreflexes, sleep apnea, and sympathetic dysregulation.

Authors:  Meghna P Mansukhani; Tomas Kara; Sean M Caples; Virend K Somers
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.